Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06596460

Single Centre Prospective Study to Obtain Data to Train an Algorithm for Prediction of Outcome in Transcatheter Aortic Valve Implantation (TAVI)

Led by Barts & The London NHS Trust · Updated on 2025-09-03

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

B

Barts & The London NHS Trust

Lead Sponsor

Q

Queen Mary University of London

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying patients with severe aortic stenosis to find out if CT scans and heart echo scans taken before a Transcatheter Aortic Valve Implantation (TAVI) can help predict how well the new valve will work over time. This study focuses on collecting detailed imaging data before and after the TAVI procedure to improve predictions of valve performance using a computer program. Participants will have a CT scan before their TAVI procedure and another CT scan six months after the procedure, which is not normally done. The study involves using these scans along with routine measures to assess any changes or deterioration in the valve. Data collected will train an algorithm to predict TAVI valve outcomes. During the study, participants will undergo imaging tests including CT and transthoracic echo scans around the time of their TAVI and at six months follow-up. Researchers will monitor valve function and complications using these images and routine clinical measures. The main outcome is obtaining quality CT imaging data at six months, with additional assessments of valve function and heart health during follow-up. Participation lasts through the six-month post-TAVI period.

CONDITIONS

Brief Title

A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Symptomatic, degenerative, tricuspid, severe aortic stenosis
  • Aortic valve area of 1.0 cm2 or less (or indexed effective orifice area 0.6 cm2/m2 or less) by transthoracic echocardiography
  • Aortic valve mean gradient 40 mmHg or more, or peak jet velocity 4.0 m/s or more, or Doppler Velocity Index 0.25 or less
  • Good quality CT TAVI scan within past 6 months
  • Good quality transthoracic echocardiogram within past 6 months with clear Doppler signals and specific velocity and gradient measurements
  • In sinus rhythm at time of TTE or CT scans
  • Successfully undergone elective TAVI using Edwards Sapien 3 Ultra valve with planned position and trivial aortic regurgitation
  • No vascular or other complications prolonging hospital discharge
Not Eligible

You will not qualify if you...

  • Life expectancy less than 6 months
  • Rockwood frailty score greater than 6
  • Mixed aortic valve disease with moderate or worse aortic regurgitation
  • Moderate to severe mitral regurgitation or mitral stenosis
  • Congenital unicuspid or bicuspid aortic valve
  • Previous TAVI or aortic valve replacement
  • Left ventricular ejection fraction less than 50%
  • Currently on or planning to start oral anticoagulation
  • Severe chronic kidney failure (eGFR less than 30 mL/min/1.73m2) or on dialysis
  • Acute myocardial infarction within 30 days before procedure
  • Untreated significant coronary artery disease needing revascularization
  • Blood disorders affecting white cells, red cells, or platelets
  • Active peptic ulcer or upper gastrointestinal bleeding within 3 months
  • Lack capacity to consent or considered vulnerable adult
  • Requires permanent pacemaker
  • Pregnancy or possibility of pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - At 6 months post TAVI

Participants undergo a specialized planning CT scan adapted for Transcatheter Aortic Valve Implantation (TAVI) to assess the heart and aortic arch at 6 months post TAVI.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

St Bartholomew's Hospital

London, England, United Kingdom, EC1A 7BE

Actively Recruiting

Loading map...

Research Team

R

R&D Governance Administrator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

Safety and Effectiveness of Balloon-Expandable Bioprosthetic...

Aortic Valve Insufficiency

Actively Recruiting

35 locations

Impact of Angiotensin Receptor Blockers in Aortic Stenosis -...

Aortic Stenosis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here